Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use

MLA

Caterina Uberti-Foppa, et al. “Resistance Mechanisms in Hepatitis C Virus: Implications for Direct-Acting Antiviral Use.” Drugs, vol. 77, May 2017, pp. 1043–55. EBSCOhost, https://doi.org/10.1007/s40265-017-0753-x.

APA

Caterina Uberti-Foppa, Giulia Morsica, & Sabrina Bagaglio. (2017). Resistance Mechanisms in Hepatitis C Virus: implications for Direct-Acting Antiviral Use. Drugs, 77, 1043–1055. https://doi.org/10.1007/s40265-017-0753-x

Chicago

Caterina Uberti-Foppa, Giulia Morsica, and Sabrina Bagaglio. 2017. “Resistance Mechanisms in Hepatitis C Virus: Implications for Direct-Acting Antiviral Use.” Drugs 77 (May): 1043–55. doi:10.1007/s40265-017-0753-x.